Santos TY, Ramos CE, Trujillo AR, Fariña PR, Valdés CJA, Vega CF

Language: Spanish
References: 14
Page: 26-31
PDF size: 153.82 Kb.

ABSTRACT

The occurrence of cardiovascular events is 10-30 times higher in hemodialysis patients than in the general population and it is the leading cause of mortality. Based on this problem a descriptive, cross-sectional and prospective study was conducted to describe the cardiovascular risk factors in patients with chronic kidney disease who initiated hemodialysis during the period from January to December 2012 in the Department of Nephrology in “Arnaldo Milián Castro” Universitary Provincial Hospital; population consisted of 63 patients with chronic kidney disease. It concluded with a predominance of male patients, the white skin and aged among 50 and 69 years; diabetic nephropathy was the most common cause of chronic kidney disease; blood hypertension, left ventricular hypertrophy and anemia were the cardiovascular risk factors most prevalent in the sample studied and most cardiovascular risk factors occurred more frequently in diabetic patients, except for smoking, which It was the only predominantly in vascular nephropathy.

REFERENCES

1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266.

2. Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2006;333:1047-50.

3. Vlagopoulos PT, Sarnak MJ. Traditional and non-traditional cardiovascular risk factors in chronic kidney disease. Med Clin North Am. 2005;89:587-611.

4. Stevinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: No longer a simple plumbing problem. J Am Soc Nephrol. 2003;14:1927-39.

5. Atiés Sánchez Mirna C, Collado Nieto S. Factores de riesgo y complicaciones cardiovasculares en pacientes con enfermedad renal crónica en hemodiálisis: prevalencia, morbilidad y mortalidad. Rev Cubana Invest Biomed [Internet]. 2012 [citado 7 Jul 2013];31(2):[aprox. 7 p.]. Disponible en: http://bvs.sld.cu/revistas/ibi/vol31_2_12/ibi08212.htm

6. Berl T, Heinrich W. Kidney-heart interactions: epidemiology, pathogenesis and treatment. Clin J Am Soc Nephrol. 2006 Jan;1(1):8-18.

7. Fariña Peláez RA. Mortalidad en hemodiálisis, factores asociados [tesis]. Santa Clara: HAMC; 2009.

8. Hillege HL, van Gilst WH, van Veldhuisen DJ, Navis G, Grobbee DE, de Graeff PA, et al. CATS Randomized Trial. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J. 2003 Mar;24(5):412-20.

9. Factores de riesgo y complicaciones cardiovasculares en los pacientes en diálisis peritoneal. Rev Cub Med Int Emerg [Internet]. 2004 [citado 7 Jul 2013];3(4):[aprox. 7 p.]. Disponible en: http://bvs.sld.cu/revistas/mie/vol3_4_04/mie07404.pdf

10. Valdés S, Rojo Martínez G, Soriguer F. Evolución de la prevalencia de la diabetes tipo 2 en población adulta española. Med Clin Barc. 2007;129(18):716-7.

11. Informe de diálisis y Trasplante 2010. Sevilla: XL Congreso Nacional de la SEN; 14- 17 Oct 2011.

12. Orth SR. Smoking and the kidney. J Am Soc Nephrol. 2002;132:1663-72.

13. Prevalencia de enfermedad cardiovascular en la uremia y relevancia de los factores de riesgo cardiovascular. Nefrología [Internet]. 2010 [citado 7 Jul 2013];30(3): [aprox. 5 p.]. Disponible en: http://www.revistanefrologia.com/modules.php?name=articulos&idarticulo=10443&i dlangart=ES

14. Chanda J, Fenves AZF. Hypertension in patients with chronic kidney disease. Curr Hypertens Rep. 2009; 11:329-36.